X0708 D LIVE 0001672180 Medcura, Inc. 5650 RIVERTECH COURT, SUITE S RIVERDALE MD MARYLAND 20737 3014053585 DELAWARE Remedium Technologies, Inc. gel-e, Inc. Remedium Technologies, INC. Corporation true Jim Buck c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Buck is the President and Chief Executive Officer of the Issuer. Larry Tiffany c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Tiffany is the Executive Chairman of the Issuer. Matthew Dowling, Ph.D c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Dr. Dowling is the Chief Scientic Officer of the Issuer. Rich Vincent c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Executive Officer Mr. Vincent is the Chief Financial Officer of the Issuer. Abbas Ardehali, M.D. c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Biotechnology Decline to Disclose 06b false 2025-04-16 false true true Convertible Promissory Notes; Series B Preferred Stock underlying the convertible promissory notes false 0 38286410 28548588 9737822 false 174 0 52183 0 false Medcura, Inc. /s/ Jim Buck Jim Buck President and CEO for the Issuer 2025-07-24